Skip to main content
T-Therapeutics  I  About

Nihal Sinha

Board Director

Nihal is a Partner at F-Prime Capital based in the London office and focuses primarily on biotech and life sciences in Europe and the US.

At F-Prime Nihal was a member of the founding team of Orchard Therapeutics and an investor in Adaptimmune, Ensoma, Charm Therapeutics and Aviado Bio.

Prior to joining F-Prime in 2013, he worked as a strategy consultant at BCG and as an academic physician at Oxford University and UCL Hospitals.

Nihal holds a MB BChir with distinction from the University of Cambridge and is a Member of the Royal College of Physicians.

T-Therapeutics
Suite 1
Riverside 3
Granta Park
Cambridge
CB21 6AD